Global /India /Healthcare /Drug Manufacturers - General /NGLFINE
chevron_leftBack
NGL Fine-Chem Ltd. logo

NGL Fine-Chem Ltd.

NGLFINE
NSE: NGLFINE Delayed
2,214.50INR -3%
23.45 USD
As of 23 June 2026, NGL Fine-Chem Ltd. has a market cap of $148.22M USD, ranking #22928 globally and #1346 in India. It ranks #2055 in the Healthcare sector, and #742 in the Drug Manufacturers - General industry.
Global Rank
22928
Country Rank
1346
Sector Rank
2055
Industry Rank
742
Key Stats
Market Cap
$148.22MUSD
14.02B INR
Enterprise Value
$151.89MUSD
14.34B INR
Revenue (TTM)
$47.25MUSD
4.47B INR
EBITDA (TTM)
$5.61MUSD
530.07M INR
Net Income (TTM)
$3.74MUSD
353.73M INR
EBITDA Margin
12%
Profit Margin
7.9%
PE Ratio
39.6
PS Ratio
3.1
PB Ratio
4.7
EV/EBITDA
27.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Rahul Nachane open_in_new
Employees
520
Founded
1981
Website
nglfinechem.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3% 1.1% 7.5% 33% 51% 104%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
NGLFINE
NGL Fine-Chem Ltd
ISIN: INE887E01022
Shares Out.:
6.178M1 Shares Float: 1.684M2
TV:
SA:
YF:
GF:
BA:
MS:
2,214.50 INR
Bombay Stock Exchange
MIC: XBOM
524774 (NGLFINE)
NGL Fine-Chem Ltd
ISIN: INE887E01022
TV:
SA:
YF:
GF:
BA:
MS:
2,268.95 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About NGL Fine-Chem Ltd.

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.13B
4.27T INR
30K%
39.1
DIVISLAB
$18.34B
1.73T INR
12K%
70.0
$15.14B
1.43T INR
10K%
63.0
$11.71B
1.11T INR
8K%
19.6
MANKIND
$9.85B
931.67B INR
7K%
52.2
ZYDUSLIFE
$9.69B
916.53B INR
6K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
514K%
38.1
JNJ
$547.28B
369K%
26.4
ABBV
$360.63B
243K%
97.4
$316.71B
256.25B CHF
214K%
19.9
AZN
$285.49B
215.59B GBP
193K%
27.6
MRK
$274.03B
185K%
15.1
chevron_leftBack